These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 8036706
1. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H. Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706 [Abstract] [Full Text] [Related]
3. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR. Wien Med Wochenschr; 1995 Jul 15; 145(21):577-83. PubMed ID: 8560901 [Abstract] [Full Text] [Related]
4. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin. Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J. J Heart Lung Transplant; 2009 Jun 15; 28(6):598-604. PubMed ID: 19481021 [Abstract] [Full Text] [Related]
5. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A. Adv Perit Dial; 1996 Jun 15; 12():261-5. PubMed ID: 8865916 [Abstract] [Full Text] [Related]
6. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug]. Mol MJ, Stuyt PM, Stalenhoef AF. Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555 [Abstract] [Full Text] [Related]
7. [Can hyperlipidemia after heart transplantation be optimally and safely treated?]. Wenke K, Thiery J, Arndtz N, Seidel D, Reichart B. Helv Chir Acta; 1994 Dec 18; 60(6):1163-8. PubMed ID: 7875999 [Abstract] [Full Text] [Related]
8. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Farnier M, Bonnefous F, Debbas N, Irvine A. Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177 [Abstract] [Full Text] [Related]
9. Simvastatin in the treatment of hypercholesterolemia in elderly patients. Antonicelli R, Onorato G, Pagelli P, Pierazzoli L, Paciaroni E. Clin Ther; 1990 Feb 28; 12(2):165-71. PubMed ID: 2354486 [Abstract] [Full Text] [Related]
10. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. Imamura R, Ichimaru N, Moriyama T, Shi Y, Namba Y, Nonomura N, Matsumiya K, Toki K, Takahara S, Okuyama A. Clin Transplant; 2005 Oct 28; 19(5):616-21. PubMed ID: 16146552 [Abstract] [Full Text] [Related]
11. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up]. Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B. Z Kardiol; 1995 Feb 28; 84(2):130-6. PubMed ID: 7717016 [Abstract] [Full Text] [Related]
12. Low-dose lovastatin safely lowers cholesterol after cardiac transplantation. Kobashigawa JA, Murphy FL, Stevenson LW, Moriguchi JD, Kawata N, Kamjoo P, Brownfield E, Wilmarth J, Leonard L, Chuck C. Circulation; 1990 Nov 28; 82(5 Suppl):IV281-3. PubMed ID: 2225417 [Abstract] [Full Text] [Related]
13. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G. Can J Cardiol; 1993 Jun 28; 9(5):405-12. PubMed ID: 8348392 [Abstract] [Full Text] [Related]
14. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group. Clin Ther; 2004 Nov 28; 26(11):1758-73. PubMed ID: 15639688 [Abstract] [Full Text] [Related]
16. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM. Liver Transpl; 2009 May 28; 15(5):504-8. PubMed ID: 19399742 [Abstract] [Full Text] [Related]
17. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women. Fak AS, Erenus M, Tezcan H, Caymaz O, Atagündüz P, Oktay S, Oktay A. Eur Heart J; 2000 Feb 28; 21(3):190-7. PubMed ID: 10639300 [Abstract] [Full Text] [Related]
18. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia. Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A. Int J Clin Pharmacol Res; 1992 Feb 28; 12(2):65-70. PubMed ID: 1428300 [Abstract] [Full Text] [Related]
19. The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression. Laufer G, Grablowitz V, Laczkovics A, Miholic J, Heinz G, Wollenek G, Schreiner W, Wolfram J, Wolner E. J Thorac Cardiovasc Surg; 1992 Aug 28; 104(2):241-7. PubMed ID: 1495285 [Abstract] [Full Text] [Related]
20. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin]. Spagnolli W, Ramponi C, Focher C, Dal Piaz A, Torboli P, Miori R, De Venuto G. Recenti Prog Med; 1996 Nov 28; 87(11):538-42. PubMed ID: 9122535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]